Literature DB >> 15107843

CD1d function is regulated by microsomal triglyceride transfer protein.

Suzana Brozovic1, Takashi Nagaishi, Masaru Yoshida, Stephanie Betz, Azucena Salas, Daohong Chen, Arthur Kaser, Jonathan Glickman, Timothy Kuo, Alicia Little, Jamin Morrison, Nadia Corazza, Jin Yong Kim, Sean P Colgan, Stephen G Young, Mark Exley, Richard S Blumberg.   

Abstract

CD1d is a major histocompatibility complex (MHC) class I-related molecule that functions in glycolipid antigen presentation to distinct subsets of T cells that express natural killer receptors and an invariant T-cell receptor-alpha chain (invariant NKT cells). The acquisition of glycolipid antigens by CD1d occurs, in part, in endosomes through the function of resident lipid transfer proteins, namely saposins. Here we show that microsomal triglyceride transfer protein (MTP), a protein that resides in the endoplasmic reticulum of hepatocytes and intestinal epithelial cells (IECs) and is essential for lipidation of apolipoprotein B, associates with CD1d in hepatocytes. Hepatocytes from animals in which Mttp (the gene encoding MTP) has been conditionally deleted, and IECs in which Mttp gene products have been silenced, are unable to activate invariant NKT cells. Conditional deletion of the Mttp gene in hepatocytes is associated with a redistribution of CD1d expression, and Mttp-deleted mice are resistant to immunopathologies associated with invariant NKT cell-mediated hepatitis and colitis. These studies indicate that the CD1d-regulating function of MTP in the endoplasmic reticulum is complementary to that of the saposins in endosomes in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107843     DOI: 10.1038/nm1043

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  63 in total

1.  Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.

Authors:  Bo Pei; Anneliese O Speak; Dawn Shepherd; Terry Butters; Vincenzo Cerundolo; Frances M Platt; Mitchell Kronenberg
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

Review 2.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

Review 3.  The role of invariant natural killer T cells in lupus and atherogenesis.

Authors:  Amy S Major; Ram R Singh; Sebastian Joyce; Luc Van Kaer
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.

Authors:  Eric Champagne; Laurent O Martinez; Pierre Vantourout; Xavier Collet; Ronald Barbaras
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 5.  Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction.

Authors:  Marianne Boes; Arie J Stoppelenburg; Fenna C M Sillé
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

Review 6.  Invariant natural killer T cells in adipose tissue: novel regulators of immune-mediated metabolic disease.

Authors:  M Rakhshandehroo; E Kalkhoven; M Boes
Journal:  Cell Mol Life Sci       Date:  2013-07-09       Impact factor: 9.261

Review 7.  Lipid transfer proteins in the assembly of apoB-containing lipoproteins.

Authors:  Alaa Sirwi; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2018-04-12       Impact factor: 5.922

Review 8.  New approaches to target microsomal triglyceride transfer protein.

Authors:  Mohammed Mahmood Hussain; Ahmed Bakillah
Journal:  Curr Opin Lipidol       Date:  2008-12       Impact factor: 4.776

Review 9.  The CD1 size problem: lipid antigens, ligands, and scaffolds.

Authors:  Dalam Ly; D Branch Moody
Journal:  Cell Mol Life Sci       Date:  2014-08       Impact factor: 9.261

Review 10.  CD1 mediated T cell recognition of glycolipids.

Authors:  Dirk M Zajonc; Mitchell Kronenberg
Journal:  Curr Opin Struct Biol       Date:  2007-10-24       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.